Bial UK Ltd. are pleased to support an evening scientific symposium in the field of Parkinson's Disease (PD). The meeting will be of interest to movement disorder specialists; neurologists; care of the elderly physicians and PD specialist nurses. The meeting will take place on 9th October 2019 beginning at 17:30 and finishing at 21:00. It will be a peer-to-peer speaker meeting with presentations from eminent specialists in the field. There will be 4 presentations related to the treatment of Parkinson’s Disease.
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world.
Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. The Bial team currently consists of 900 workers. We bring together our knowledge, experience, imagination and dedication to achieve a concrete goal: providing high quality medicines. 79% of our workers have higher education qualifications, 7% of which are PhDs.